Tandem high dose chemotherapy for non-hodgkin's lymphoma and hodgkin's disease utilizing cyclophosphamide, etoposide and carboplatin followed by melphalan and carboplatin with autologous stem cell transplantation

Jeffrey Andrey, Carol Burian, Robert McMillan, William E. Miller, Barry Meisenberg, James R. Mason

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Tandem high dose chemotherapy for non-hodgkin's lymphoma and hodgkin's disease utilizing cyclophosphamide, etoposide and carboplatin followed by melphalan and carboplatin with autologous stem cell transplantation'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds